191 related articles for article (PubMed ID: 37430276)
1. Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT.
Xiang G; Xu C; Chai G; Lyu B; Li Z; Wang B; Shi M; Zhao L
Radiat Oncol; 2023 Jul; 18(1):114. PubMed ID: 37430276
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
Xu X; Wang Z; Jiang S; Shang Y; Wu Y
Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis.
Zhao K; Si Y; Sun L; Meng X; Yu J
Radiat Oncol; 2020 Oct; 15(1):243. PubMed ID: 33087143
[TBL] [Abstract][Full Text] [Related]
4. A re-irradiation dose of 55-60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy.
Wu X; Hu X; Chen J; He L
Radiat Oncol; 2021 Jun; 16(1):100. PubMed ID: 34103059
[TBL] [Abstract][Full Text] [Related]
5. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
Chen J; Yin W; Yao H; Gu W
Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
[TBL] [Abstract][Full Text] [Related]
6. Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis.
Hong L; Huang YX; Zhuang QY; Zhang XQ; Tang LR; Du KX; Lin XY; Zheng BH; Cai SL; Wu JX; Li JL
Radiat Oncol; 2018 Sep; 13(1):171. PubMed ID: 30201005
[TBL] [Abstract][Full Text] [Related]
7. Comparison of three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, and volumetric-modulated arc therapy in the treatment of cervical esophageal carcinoma.
Yang H; Feng C; Cai BN; Yang J; Liu HX; Ma L
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27629865
[TBL] [Abstract][Full Text] [Related]
8. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study.
Lan W; Lihong L; Chun H; Shutang L; Qi W; Liang X; Xiaoning L; Likun L
Strahlenther Onkol; 2022 Sep; 198(9):802-811. PubMed ID: 35029718
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy with more than 60 Gy improved the survival of inoperable patients with locally advanced esophageal squamous cell carcinoma: A population-based real-world study.
Zhang W; Xie Q; Zhu B; Wang X; He L; Zhang Y
Medicine (Baltimore); 2022 Apr; 101(16):e29166. PubMed ID: 35482986
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
Lu N; Wang X; Li C; Wang L; Chen JQ; Zhang WC; Wang XM; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Xiao ZF; Zhu SC; Han C; Qiao XY; Pang QS; Wang P; Zhao YD; Sun XC; Zhang KX; Li L; Li GF; Liu ML; Wang YD
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):139-144. PubMed ID: 32135649
[No Abstract] [Full Text] [Related]
11. Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score-matched analysis.
Li C; Tan L; Liu X; Wang X; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Wang X; Bi N; Deng L; Wang W; Zhang T; Ni W; Chang X; Han W; Gao L; Wang S; Xiao Z
Thorac Cancer; 2021 Jun; 12(12):1831-1840. PubMed ID: 33949784
[TBL] [Abstract][Full Text] [Related]
12. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G
Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience.
Xu Y; Wang Z; Liu G; Zheng X; Wang Y; Feng W; Lai X; Zhou X; Li P; Ma H; Wang J; Hu X; Chen M
J Cancer Res Ther; 2016 Oct; 12(Supplement):82-88. PubMed ID: 27721262
[TBL] [Abstract][Full Text] [Related]
14. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
[TBL] [Abstract][Full Text] [Related]
15. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative.
Ward MC; Riaz N; Caudell JJ; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Vargo JA; Heron DE; Higgins KA; Beitler JJ; Marcrom S; Boggs DH; Hassanzadeh C; Reddy CA; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA;
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):586-594. PubMed ID: 28865925
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and Prognostic Factors of Salvage Radiation for Postoperative Lymph Node Recurrence of Esophageal Squamous Cell Carcinoma.
Zhang C; Ge XL; Huang CJ; Zhang S; Sun XC
Front Oncol; 2021; 11():638521. PubMed ID: 33816281
[No Abstract] [Full Text] [Related]
17. Survival analysis of 80 elderly patients with esophageal squamous cell carcinoma receiving definitive concurrent chemoradiotherapy with S-1.
Ran JJ; Shen JJ; Ma J; Li XY
Cancer Radiother; 2022 Nov; 26(8):1064-1069. PubMed ID: 35864071
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of re-irradiation for locoregional esophageal squamous cell carcinoma recurrence after radiotherapy: a systematic review and meta-analysis.
Lan K; Chen J
Radiat Oncol; 2022 Mar; 17(1):61. PubMed ID: 35346285
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy Alone or Concurrent Chemoradiation for Esophageal Squamous Cell Carcinoma in Elderly Patients.
Zhao L; Zhou Y; Pan H; Yin Y; Chai G; Mu Y; Xiao F; Lin SH; Shi M
J Cancer; 2017; 8(16):3242-3250. PubMed ID: 29158796
[No Abstract] [Full Text] [Related]
20. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
